Appili Therapeutics Inc. Forecasted to Post Q1 2023 Earnings of ($0.03) Per Share (TSE:APL)
Appili Therapeutics Inc. Forecasted to Post Q1 2023 Earnings of ($0.03) Per Share (TSE:APL)
Appili Therapeutics Inc. (TSE:APL – Get Rating) – Equities researchers at Zacks Small Cap issued their Q1 2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a research note issued on Thursday, July 14th. Zacks Small Cap analyst D. Bautz anticipates that the company will post earnings per share of ($0.03) for the quarter. Zacks Small Cap also issued estimates for Appili Therapeutics' Q2 2023 earnings at ($0.02) EPS, Q3 2023 earnings at ($0.02) EPS and Q4 2023 earnings at ($0.02) EPS.
Appili治療公司(多倫多證券交易所股票代碼：APL-GET評級)--Zack Small Cap的股票研究人員在7月14日星期四發佈的一份研究報告中發佈了他們對Appili治療公司股票2023年第一季度每股收益(EPS)的估計。Zack Small Cap分析師D·鮑茨預計，該公司本季度每股收益將達到0.03美元。Zack Small Cap還發布了對Appili Treeutics 2023年第二季度每股收益(0.02美元)、2023年第三季度每股收益(0.02美元)和2023年第四季度每股收益(0.02美元)的估計。
Appili Therapeutics Price Performance
阿普利治療公司性價比
See Also
另請參閲
- MarketBeat: Week in Review 7/11 – 7/15
- Is Coupang's Stock On The Verge Of A Turnaround?
- Should You Have These Two Banks In Your Portfolio?
- Verint Systems Stock is a Customer Engagement Play
- Why Shopify Stock Split...And is as Shoppable as Ever
- MarketBeat：回顧一週7/11-7/15
- Coupang的股票即將翻身嗎？
- 你的投資組合中應該有這兩家銀行嗎？
- Verint Systems Stock是一場客户互動活動
- 為什麼Shopify股票拆分...並一如既往地適合購物
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
獲得《阿普利治療日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Appili Treateutics和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。